Girault I - Search Results

1

Expression analysis of estrogen receptor alpha coregulators in breast carcinoma: evidence that NCOR1 expression is predictive of the response to tamoxifen.

Girault I, Lerebours F, Amarir S, Tozlu S, Tubiana-Hulin M, Lidereau R, Bièche I. Girault I, et al. Clin Cancer Res. 2003 Apr;9(4):1259-66. Clin Cancer Res. 2003. PMID: 12684393

2

Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

Girault I, Tozlu S, Lidereau R, Bièche I. Girault I, et al. Clin Cancer Res. 2003 Oct 1;9(12):4415-22. Clin Cancer Res. 2003. PMID: 14555514

3

Expression of PEA3/E1AF/ETV4, an Ets-related transcription factor, in breast tumors: positive links to MMP2, NRG1 and CGB expression.

Bièche I, Tozlu S, Girault I, Onody P, Driouch K, Vidaud M, Lidereau R. Bièche I, et al. Among authors: girault i. Carcinogenesis. 2004 Mar;25(3):405-11. doi: 10.1093/carcin/bgh024. Epub 2003 Nov 21. Carcinogenesis. 2004. PMID: 14633660

4

Relationship between intratumoral expression of genes coding for xenobiotic-metabolizing enzymes and benefit from adjuvant tamoxifen in estrogen receptor alpha-positive postmenopausal breast carcinoma.

Bièche I, Girault I, Urbain E, Tozlu S, Lidereau R. Bièche I, et al. Among authors: girault i. Breast Cancer Res. 2004;6(3):R252-63. doi: 10.1186/bcr784. Epub 2004 Mar 26. Breast Cancer Res. 2004. PMID: 15084249 Free PMC article.

5

Altered expression pattern of alternatively spliced estrogen receptor beta transcripts in breast carcinoma.

Girault I, Andrieu C, Tozlu S, Spyratos F, Bièche I, Lidereau R. Girault I, et al. Cancer Lett. 2004 Nov 8;215(1):101-12. doi: 10.1016/j.canlet.2004.05.006. Cancer Lett. 2004. PMID: 15374639

6

Identification of a three-gene expression signature of poor-prognosis breast carcinoma.

Bièche I, Tozlu S, Girault I, Lidereau R. Bièche I, et al. Among authors: girault i. Mol Cancer. 2004 Dec 20;3(1):37. doi: 10.1186/1476-4598-3-37. Mol Cancer. 2004. PMID: 15606925 Free PMC article.

7

Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer.

Girault I, Bièche I, Lidereau R. Girault I, et al. Maturitas. 2006 Jul 20;54(4):342-51. doi: 10.1016/j.maturitas.2006.06.003. Epub 2006 Jul 5. Maturitas. 2006. PMID: 16822624 Review.

8

Real-time reverse transcription PCR assay of CYP19 expression: application to a well-defined series of post-menopausal breast carcinomas.

Girault I, Lerebours F, Tozlu S, Spyratos F, Tubiana-Hulin M, Lidereau R, Bièche I. Girault I, et al. J Steroid Biochem Mol Biol. 2002 Nov;82(4-5):323-32. doi: 10.1016/s0960-0760(02)00190-5. J Steroid Biochem Mol Biol. 2002. PMID: 12589939

9

Prognostic value of maspin mRNA expression in ER alpha-positive postmenopausal breast carcinomas.

Bièche I, Girault I, Sabourin JC, Tozlu S, Driouch K, Vidaud M, Lidereau R. Bièche I, et al. Among authors: girault i. Br J Cancer. 2003 Mar 24;88(6):863-70. doi: 10.1038/sj.bjc.6600812. Br J Cancer. 2003. PMID: 12644823 Free PMC article.

10

Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.

Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I. Tozlu S, et al. Among authors: girault i. Endocr Relat Cancer. 2006 Dec;13(4):1109-20. doi: 10.1677/erc.1.01120. Endocr Relat Cancer. 2006. PMID: 17158757

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters